top of page



Biosca-Brull, J., Ona, G., Alarcón-Franco, L., & Colomina, M.T. (2024). A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets. Translational Psychiatry, 14(1), 41. doi: 10.1038/s41398-024-02773-7.

David, J., Bouso, J.C., Kohek, M., Ona, G., Tadmor, N., Arnon, T., Dor-Ziderman, Y., & Berkovich-Ohana, A. (2023). Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment. Frontiers in Psychiatry, 14. 

Sainz-Cort, A., Martín-Islas, M., Ona, G., Jiménez-Garrido, D., López-Navarro, M., Muñoz-Marron E, Viejo-Sobera, R., & Bouso, J.C., & (2023). Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis. International Clinical Psychopharmacology. Doi: 10.1097/YIC.0000000000000498


Kohek, M., Bouso, J.C., & Ona, G. (2023). De crecer en la selva a practicar la ayahuasca en la ciudad: una exploración de la globalización de la ayahuasca en términos de autenticidad, autoatención y de los retos de dicha globalización para la antropología médica. Revista de Antropología Social, 32(2), 141-154. Doi: 10.5209/raso.91747

Ona, G., Reverte, I., Rossi, G. N., Dos Santos, R. G., Hallak, J. E., Colomina, M. T., & Bouso, J. C. (2023). Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview. Journal of Psychopharmacology. Doi: 10.1177/02698811231200882

Ona, G. (2023). Uso ritual de alucinógenos y medicina psicodélica: Articulaciones alrededor del uso clínico de la ayahuasca en Brasil. Quaderns de l'Institut Català d'Antropologia, 39(1), 198-219. doi: 10.56247/qua.401

Bouso, J.C., Révész, D., Ona, G., Rossi, G.N., Rocha, J.M., dos Santos, R.G., Hallak, J.E.C., & Alcázar-Córcoles, M.A. (2023). Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic. Scientific Reports, 13(1), doi: 10.1038/s41598-023-41199-x 

Rossi, G.N., Rocha, J.M., Osório, F.L., Bouso, J.C., Ona, G., Silveira, G.dO., Yonamine, M., Bertozi, G., Crevellin, E.J., Queiroz, M.E., Crippa, J.A.S., Hallak, J.E.C., & dos Santos, R.G. (2023). Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers. Journal of Clinical Psychopharmacology, doi: 10.1097/JCP.0000000000001691

Santos, G.H.dM., Rodrigues, L.S., Rocha, J.M., Rossi, G.N., Ona, G., Bouso, J.C., Hallak, J.E.C., dos Santos, R.G. (2023). Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies. Psychoactives, 2(1), 76-91. doi: 10.3390/psychoactives2010006

Hidalgo-Jiménez, J., Ona, G., Alcázar-Córcoles, M.A., & Bouso, J.C. (2023). Cannabis and public health: A study assessing regular cannabis users through health indicators. Cannabis and Cannabinoid Research. doi: 10.1089/can.2022.0231


Bouso, J.C., Ona, G., Kohek, M., dos Santos, R.G., Hallak, J.E.C., Alcázar-Córcoles, M.A., & Obiols-Llandrich, J. (2023). Hallucinations and Hallucinogens: Psychopathology or Wisdom? Culture, Medicine and Psychiatry. doi: 10.1007/s11013-022-09814-0

Rodriguez-Cano, B., Kohek, M., Ona, G., Alcázar-Córcoles, M.A., dos Santos, R.G., Hallak, J.E.C., & Bouso, J.C. (2022). Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences. Drug and Alcohol Review, 42, 401-414. doi: 10.1111/dar.13587

Ona, G., Révész, D., Kohek, M., Rossi, G.N., Rocha, J.M., dos Santos, R.G., Hallak, J.E.C., Alcázar-Córcoles, M.A., & Bouso, J.C. (2022).Tripping to Cope: Coping Strategies and Use of Hallucinogens during the COVID-19 Pandemic in Three Cultural Contexts. Psychoactives, 1, 16-30. doi: 10.3390/psychoactives1010003


Ona, G., Kohek, M., & Bouso, J.C. (2022).The modern clinical use of hallucinogens. What can we learn from the natural product research? Natural Product Research. doi: 10.1080/14786419.2022.2103697

Ona, G., Kohek, M., & Bouso, J.C. (2022). The illusion of knowledge in the emerging field of psychedelic research. New Ideas in Psychology, 67, 100967.

Kohek, M., Ona, G., van Elk, M., dos Santos, R.G., Hallak, J.E.C., Alcázar-Córcoles, M.A., & Bouso, J.C. (2022). Ayahuasca and public health II: Health status in a large sample of ayahuasca-ceremony participants in the Netherlands. Journal of Psychoactive Drugs, 55, 247-258. doi: 10.1080/02791072.2022.2077155

Jiménez-Vinaja, R., Imbernón, M., Parés-Bayerri, A., Ona, G., Parés, O., & Bouso, J.C. (2022). Jailhouse rock: Estado de salud, patrones de consumo y beneficios subjetivos del uso de cannabis en una muestra de reclusos en prisiones españolas. Revista Española de Sanidad Penitenciaria, 24(1), 9-15.

dos Santos, R. G., Rocha, J. M., Rossi, G. N., Osório, F. L., Ona, G., Bouso, J. C., Silveira, G. d. O., Yonamine, M., Marchioni, C., Crevelin, E. J., Queiroz, M. E., Crippa, J. A., & Hallak, J. E. C. (2022). Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Human Psychopharmacology: Clinical and Experimental, 37, e2834.

Ona, G., Sampedro, F., Romero, S., Valle, M., Camacho, V., Migliorelli, C., Mañanas, M.A., Antonijoan, R.M., Puntes, M., Coimbra, J., Ballester, M.R., Garrido, M., Riba, J. (2022). The kappa opioid receptor and the sleep of reason: Cortico-subcortical imbalance following salvinorin-A. International Journal of Neuropsychopharmacology, 25(1), 54-63.


Ona, G., Balant, M., Bouso, J.C., Gras, A., Vallès, J., Vitales, D., Garnatje, T. (2021). The use of Cannabis sativa L. for pest control: From the ethnobotanical knowledge to a systematic review of experimental studies. Cannabis and Cannabinoid Research. doi: 10.1089/can.2021.0095


Jiménez-Garrido, D.F., Ona, G., Cura, P., Parès, A., Bismara Paranhos, B.A.P., Mendes, F.A., Yonamine, M., dos Santos, R.G., Hallak, J.E.C., Alcázar-Córcoles, M.A., Bouso, J.C. (2021). Avaluació de l’estat de salut, els patrons de consum i els beneficis subjectius del cànnabis medicinal en una mostra de pacients catalans amb malalties cròniques. Circular Farmacèutica, 79(2), 15-19.

Ona, G., Rocha, J.M., Bouso, J.C., Hallak, J.E.C., Borràs, T., Colomina, M.T., dos Santos, R.G. (2021). The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology. doi: 10.1007/s00213-021-05964-y

Révész, D.Ona, G.Rossi, G.N., Rocha, J.M., Dos Santos, R.G., Hallak, J.E.C., Alcázar-Córcoles, M.A., Bouso, J.C. (2021). Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: A transcultural study. Frontiers in Psychiatry, 12, 687546.

Bouso, J.C., Ona, G., dos Santos, R.G., & Hallak, J.E.C. (2021). Psychedelic medicines in Major Depression: Progress and future challenges. In Y.K. Kim (Ed.), Major Depressive Disorder: Current research and management approaches. Springer Nature.


Ona, G., Berrada, A., & Bouso, J.C. (2021). Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement. Transcultural Psychiatry. doi: 10.1177/13634615211038416


Gómez-Sousa, M, Jiménez-Garrido, D.F., Ona, G., dos Santos, R.G., Hallak, J.E.C., Alcázar-Córcoles, M.Á., & Bouso, J.C. (2021). Acute psychological adverse reactions in first-time ritual ayahuasca users. Journal of Clinical Psychopharmacology, 41(2), 163-171.


Ona, G. & Bouso, J.C. (2020). Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. Neuroscience and Biobehavioral Reviews, 119, 194-203.


Ona, G., dos Santos, R.G., Hallak, J.E.C., & Bouso, J.C. (2020). Polypharmacology or "pharmacological promiscuity" in psychedelic research: What are we missing? ACS Chemical Neuroscience, 11(20), 3191-3193.


Ona, G. (2020). Elaboración y validación de un cuestionario para la detección del riesgo de reacciones adversas graves por empleo de drogas psicodélicas en terapia. International Journal of Psychology and Psychological Therapy, 20(2), 211-22.


Jiménez-Garrido, D., Gómez-Sousa, M., Ona, G., et al. (2020). Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination. Scientific Reports, 10, 4075. Paper among the Top 100 most downloaded papers of Scientific Reports during 2020.


Bouso, J.C., Jiménez-Garrido, D., Ona, G., et al. (2020). Quality of life, mental health, personality, and patterns of use in self-medicated cannabis users with chronic diseases: a 12-month longitudinal study. Phytotherapy Research, 34(7), 1670-1677.


Ona, G. & Bouso, J.C. (2019). Therapeutic potential of natural psychoactive drugs for central nervous system disorders: A perspective from polypharmacology. Current Medicinal Chemistry, 28(1), 53-68.


Ona, G., Kohek, M., Massaguer, T., et al. (2019). Ayahuasca and public health: health Status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. Journal of Psychoactive Drugs, 51(2), 135-145.


Aixalà, M., Ona, G., Parés, Ò., & Bouso, J.C. (2019). Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users. Drugs: Education, Prevention and Policy, 27(3), 191-198.


Ona, G. & Troncoso, S. (2019). Long-lasting analgesic effect of the psychedelic drug changa: A case report. Journal of Psychedelic Studies, 3(1), 7-13.


Ona, G. (2018). Consideraciones sobre el estado actual de la terapia psicodélica: Limitaciones, sesgos y propuestas metodológicas. Cultura y Droga, 23(26), 37-47.


Ona, G. (2018). Inside bad trips: Exploring extra-pharmacological factors. Journal of Psychedelic Studies, 2(1), 53-60.

Ona, G., & Spuch, J. (2016). What happens after your first trip? A longitudinal, prospective, pragmatic-oriented study. Journal of Transpersonal Research, 8(1), 41-54.


Ona, G. (2022). Your brain on psychedelics: Pharmacology and neuroscience of psilocybin, DMT, LSD, MDMA, mescaline. Nowtilus. Madrid, Spain.


Ona, G., & Bouso, J.C. (2021). Towards the use of whole natural products in psychedelic research and therapy: Synergy, multi-target profiles, and beyond. In A. Rahman (Ed.), Frontiers in Natural Product Chemistry. Bentham Science publishers.

Bouso, J.C., Ona, G., dos Santos, R.G., & Hallak, J.E.C. (2021). Psychedelic medicines in Major Depression: Progress and future challenges. In Y.K. Kim (Ed.), Major Depressive Disorder: Current research and management approaches. Springer Nature.

Kohek, M., Ona, G., & Bouso, J.C. (2020). Psychedelics in times of pandemic outbreaks. In S. Evangelidou, A. Martínez-Hernáez (Eds.), RESET: Reflexiones antropológicas ante la pandemia de COVID-19. Tarragona, Spain: Publicacions URV. Winner of the XXIV Premios Nacionales de Edición Universitaria, Best Monography in Health Sciences.


bottom of page